Cypherpunk Technologies Inc. CYPH FINANCIAL
Company Overview
Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
Why Investors Should Care
Trades at a P/E of 4.1, below the sector median of 12.9.
Carries low leverage with a debt-to-equity ratio of 0.03.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue +0.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 0.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 0.00% |
| 1 Year: | 0.00% |
Stock Price Performance
| 1 Year: | +675.81% |
| 6 Months: | +384.35% |
| 3 Months: | +271.47% |
| 1 Month: | +281.71% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross1d ago
- RSI (14)83.42 · Overbought
P/E of 4.11 is below the sector median of 12.89 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- RSI at 83 suggests overbought conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CYPH Cypherpunk Technologies Inc. FINANCIAL | 2.63 | 4.11 | $280.00M | 0.00% | -25.89% | -1.21% | 0.00% | - |
| 2 | JPM JPMorgan Chase & Co. SPXR3KFINANCIAL | 353.51 | 15.15 | $939.70B | 1.72% | - | 17.79% | 12.50% | 14.83% |
| 3 | BRK-B Berkshire Hathaway Inc. SPXFINANCIAL | 505.83 | 12.72 | $712.23B | 0.00% | - | 12.12% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPXR3KFINANCIAL | 368.64 | 31.35 | $628.20B | 0.72% | 37.15% | 61.19% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPXR3KFINANCIAL | 570.89 | 31.44 | $496.37B | 0.62% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPXR3KFINANCIAL | 62.39 | 14.41 | $436.28B | 2.04% | - | 11.20% | 3.14% | 4.27% |
| 7 | BRK-A Berkshire Hathaway Inc. FINANCIAL | 757,791.00 | 12.71 | $370.14B | 0.00% | - | 12.12% | 7.60% | 10.02% |
| 8 | HSBC HSBC Holdings plc FINANCIAL | 106.26 | 15.18 | $363.70B | 3.65% | - | 13.10% | 9.75% | 12.72% |
| 9 | MS Morgan Stanley SPXR3KFINANCIAL | 216.24 | 17.48 | $339.62B | 2.26% | - | 17.97% | 3.76% | 9.66% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 375.00K | 375.00K | 375.00K | 375.00K | 375.00K | 375.00K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | -5.14M | -7.19M | -7.03M | -10.21M | -7.02M | -8.58M | -6.34M | -6.84M | -8.60M | -8.79M | -8.46M | -7.92M | -6.38M | -7.50M | -7.51M | -9.17M | -9.63M | -12.14M | -10.63M | -16.90M | -15.29M | -42.73M | -14.66M | -14.83M | -14.82M | -21.25M | -17.86M | -15.92M | -16.88M | -3.17M | -4.82M |
| Net Income | -5.15M | -7.48M | -7.28M | -9.41M | -6.91M | -6.82M | -10.62M | -7.36M | -6.63M | -8.60M | -8.37M | -7.93M | -7.23M | -6.52M | -7.06M | -9.13M | -9.53M | -11.14M | -10.38M | -17.02M | -15.09M | -41.86M | -13.39M | -13.70M | -13.82M | -20.13M | -18.18M | -15.44M | -16.64M | -3.30M | -77.17M |
| Diluted EPS | - | - | - | - | - | -0.73 | - | - | -0.55 | -0.47 | -0.37 | -0.33 | -0.55 | -0.12 | -0.09 | -0.12 | -0.12 | -0.14 | -0.09 | -1.50 | -1.33 | -3.24 | -0.91 | -0.51 | -0.51 | -0.52 | -0.44 | -0.37 | -0.40 | -0.08 | -0.46 |
| R&D Expense | 4.09M | 6.12M | 5.66M | 6.40M | 4.88M | 6.80M | 4.23M | 4.23M | 6.46M | 6.79M | 6.14M | 5.77M | 4.60M | 5.35M | 5.37M | 6.81M | 7.21M | 10.08M | 7.78M | 14.04M | 12.10M | 38.94M | 11.10M | 11.50M | 11.30M | 17.89M | 14.91M | 12.91M | 10.54M | 1.25M | 161.00K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 1.50M | 1.50M | - | - | - | - |
| Operating Income | -27.30M | -32.35M | -30.75M | -33.45M | -28.54M | -41.43M | -56.76M | -87.04M | -70.06M | -41.07M |
| Net Income | -25.63M | -29.73M | -23.14M | -32.90M | -27.51M | -40.59M | -54.60M | -81.41M | -67.56M | 4.82M |
| Diluted EPS | - | -3.31 | -2.11 | -1.47 | -0.63 | -0.47 | -4.82 | -3.98 | -1.81 | 0.07 |
| R&D Expense | 23.29M | 22.50M | 21.83M | 24.37M | 20.42M | 32.16M | 44.97M | 73.23M | 57.21M | 25.67M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 6.46M | 29.06M | 19.07M | 7.45M | 54.37M | 117.91M | 70.35M | 72.83M | 49.12M | 163.18M |
| Total Equity | -70.29M | -100.23M | 11.12M | 9.18M | -1.75M | 46.65M | 107.89M | 58.87M | 60.14M | 35.05M | 153.51M |
| Cash & Equivalents | - | 793.00K | 25.74M | 16.28M | 3.89M | 52.07M | 114.92M | 65.50M | 70.64M | 47.25M | 14.04M |
| Total Liabilities | - | 36.16M | 17.95M | 9.90M | 9.20M | 7.72M | 10.02M | 11.49M | 12.68M | 14.08M | 9.68M |
| Current Liabilities | - | 36.16M | 6.08M | 6.45M | 8.49M | 7.37M | 9.99M | 11.22M | 12.68M | 14.08M | 4.56M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -25.34M | -22.14M | -26.03M | -26.90M | -25.96M | - | -49.04M | -43.75M | -60.30M | -43.90M |
| Investing Cash Flow | -144.00K | -64.00K | - | -85.00K | 25.00K | - | 0 | 48.97M | 0 | -97.00M |
| Financing Cash Flow | 25.62M | 47.76M | 15.91M | 14.82M | 74.00M | - | -210.00K | -30.00K | 37.18M | 107.65M |
| Capital Expenditure | -144.00K | -64.00K | - | -100.00K | - | - | - | - | - | -97.00M |
| Free Cash Flow | -25.48M | -22.20M | - | -27.00M | - | - | -49.04M | -43.75M | -60.30M | -140.90M |
| Net Change in Cash | - | - | - | - | - | - | -49.25M | 5.19M | -23.11M | -33.25M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | -1,902.6% | -2,761.7% | - | - | - | - |
| Net Margin % | - | - | - | - | -1,834.3% | -2,705.8% | - | - | - | - |
| ROE % | 25.6% | -267.4% | -252.2% | 1,881.1% | -59.0% | -37.6% | -92.7% | -135.4% | -192.7% | 3.1% |
| ROCE % | 91.9% | -140.8% | -243.6% | 3,222.6% | -60.7% | -38.4% | -96.0% | -144.7% | -199.9% | -25.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Vanguard Capital Management LLC | 3.61% | 3.89M | $14.00M |
| 2 | Blackrock Inc. | 2.43% | 2.62M | $9.44M |
| 3 | Jane Street Group, LLC | 1.58% | 1.70M | $6.13M |
| 4 | Geode Capital Management, LLC | 1.09% | 1.17M | $4.23M |
| 5 | UBS Group AG | 1.05% | 1.13M | $4.06M |
| 6 | Citadel Advisors Llc | 0.78% | 836.15K | $3.01M |
| 7 | Xtx Topco Ltd | 0.59% | 638.33K | $2.30M |
| 8 | Vanguard Fiduciary Trust Co | 0.53% | 571.35K | $2.06M |
| 9 | State Street Corporation | 0.48% | 516.11K | $1.86M |
| 10 | Cygnus Capital Advisors, LLC | 0.23% | 246.46K | $887.25K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CYPH
CYPH Stock Extends Breakout As Traders Pile Into Momentum - timothysykes.com
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxPVGNhbm5jNk1KMTZjZ2plTXQ5LXB6V1R0d2pnUncxZEVyTlhiZnBlWElrOTlIZDl2TzlaN1pUS3lnLVUxZUlBY1NYY0RpZm1TbnVxTkxiWkExOWc4MzB2SDdXbF9UWjNIRUg0QmlLa2xhM3hPNjRaN1Awa21oMlVKZG4zTnlXUQ?oc=5" t…
CYPH Stock Breaks Out As Traders Eye Volatile Run - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNMkcxOXlPeXFJaGtBQ3ZjX2JHclp2R0V5SzZERWlpWnEydDBjYmxoZXR0WmtXZDBabHlsN1JNSUNtZmZVY2NoR2hYZjlvaXRjN1lPQzhKSTRHWVE3Rk5aTlBoMTFvT2Vla1AzYTV2WjN2MmlWMWVhWDZpZURXajJTcGo0UzBJSkk?oc=5" …
Cypherpunk rejects Robinhood's unauthorized ZEC token amid Zcash price surge and criticism. - Pluang
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOek5XaFA0MWVQbTRWemROS3NUVDlkeTR0UkNVMHhSN2hhY1l1RUFZWEh6bkJpMkc2bDZGc0RKRHdjQzVSVWNsc2xjZTd0Yml2Wnd1ZGwyLVlvdVdDNzViNnp6UGJFVGVTRUw4ZHVCWXg5X2FQdTdZTGNISFE2aTBWbDhhUXZzQlZ5ZzRNMn…
Cypherpunk's U.S. mining fleet now represents about 18% of Zcash's network - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPanp6OUdhUGpLX0tydzA3ME1LR3hEcTRGVjFhb2V5cnV2Q01nczhobWdDZnlfQkJXQkNBLWRIX1dPWEZ5V2VwUjNzejlBSzk2VGV4Y2NMVDc0TnplNEFWdThsSmFFcl9sX0JUZXdaaDBrZmVGRGNHdTVLR2M2MVd2eno2aDBMOTdXZDkyR3…
Market Movers | Winners: CYPH, ABTC, MRLN | Losers: RARE, MEI, METC - Trefis
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNNWtmYktxTTMxcGdGWGtBWDJGWkdvdTlmdnRLM3hQeEVLNHkyb3dsYWN4UU4zUlZiSG0tcGxndkFvQ00zcXQwS3VqOE1uMEFmOW9oT1FHSUMzUkx4MFJkc2VjYUtubEwyVlY3LTJUczVGOThtbGVLTkxUTnRKemN6MFlTNDJXUC1fWmhtQ2…
$CYPH stock is down 13% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQZndtR1FXNFBuTTlJRXYxS2l5WEJia2JxYng1SlZoN01lTXk2Mmh2TFpfd2NCYzM3NVVxRzRzby11c2thOU02WGtSQ2JQZmVaa3JfNERGRmNyUUN3WDcyS0x1TkdmblVOWElINHptdnZtUS1DbGtSUFBGVGo5eTJDbE1RbktvczloZ3FXZz…
CYPH — Frequently Asked Questions
What is the current share price of Cypherpunk Technologies Inc. (CYPH)?
As of 2026-09-19 21:16 PDT, Cypherpunk Technologies Inc. (CYPH) trades at $2.63 on NasdaqCM. Its 52-week range is $0.24 to $2.97.
What is the market capitalisation of CYPH?
Cypherpunk Technologies Inc. (CYPH) has a market capitalisation of $280.00M on NasdaqCM.
What is the P/E ratio of CYPH?
CYPH trades at a trailing price-to-earnings (P/E) ratio of 4.11. The industry average P/E is 12.89. Its price-to-book (P/B) ratio is 1.89.
What is the return on equity (ROE) of CYPH?
CYPH has a return on equity (ROE) of -1.21%. Its return on capital employed (ROCE) is -25.89%.
Is CYPH a good stock to buy?
This page provides a data-driven analysis of Cypherpunk Technologies Inc. (CYPH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.